Hiroshi Kuga
Impact in
- Toxicology top 2%
- Bioactive Compounds and Antitumor Agents
- Oncology top 5%
- Lung Cancer Research Studies
- Neutropenia and Cancer Infections
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
Papers in
-
- Cancer therapeutics and mechanisms 8
- Biochemical and Molecular Research 3
- Oncology 7
- Peptidase Inhibition and Analysis 3
- Co-authors
- Keiki Sato (4 shared papers)Yasuyoshi Kawato (2 shared papers)Yasuhide Hirota (2 shared papers)Masashi Aonuma (1 shared paper)Satoshi Ōmura (6 shared papers)Nobutaka Imamura (6 shared papers)Yoshinobu Shiose (5 shared papers)Mitsuru Hashida (3 shared papers)
- Journals
- The Journal of Antibiotics (6 papers)Bioscience Biotechnology and Biochemistry (2 papers)Xenobiotica (2 papers)Biochemical and Biophysical Research Communications (1 paper)Bioconjugate Chemistry (1 paper)
- Partner nations
- JapanGermanyUnited States
In The Last Decade
Hiroshi Kuga
27 papers receiving 1.3k citations
Hiroshi Kuga's Hit Papers
Peers
Comparison fields: 5 of 90
- Toxicology 96
- Oncology 531
- Molecular Biology 770
- Pharmacology 158
- Biomaterials 104
Countries citing papers authored by Hiroshi Kuga
This map shows the geographic impact of Hiroshi Kuga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Kuga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Kuga more than expected).
Fields of papers citing papers by Hiroshi Kuga
This network shows the impact of papers produced by Hiroshi Kuga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Kuga. The network helps show where Hiroshi Kuga may publish in the future.
Co-authors
The 25 scholars most cited alongside Hiroshi Kuga, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11. Hit paper breakdown → | 1991 | 763 |
| 2 | 1986 | 64 | |
| 3 | 1990 | 59 | |
| 4 | 1997 | 59 | |
| 5 | 2020 | 52 | |
| 6 | 2007 | 45 | |
| 7 | 1993 | 38 | |
| 8 | 1989 | 29 | |
| 9 | 2004 | 26 | |
| 10 | 1985 | 24 | |
| 11 | 1993 | 23 | |
| 12 | 2015 | 20 | |
| 13 | 2008 | 16 | |
| 14 | 2004 | 14 | |
| 15 | 2017 | 14 | |
| 16 | 1986 | 12 | |
| 17 | 1986 | 12 | |
| 18 | 2007 | 10 | |
| 19 | 1997 | 9 | |
| 20 | 1992 | 9 |
About Hiroshi Kuga
Hiroshi Kuga is a scholar working on Molecular Biology, Oncology, Pharmacology, Toxicology and Biomaterials, having authored 28 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (8 papers), Nanoparticle-Based Drug Delivery (4 papers), Bioactive Compounds and Antitumor Agents (4 papers), Peptidase Inhibition and Analysis (3 papers), Biochemical and Molecular Research (3 papers), Microbial Natural Products and Biosynthesis (3 papers), HIV/AIDS drug development and treatment (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). The work is most often cited by research in Toxicology (96 citations), Oncology (531 citations), Molecular Biology (770 citations), Pharmacology (158 citations) and Biomaterials (104 citations). Hiroshi Kuga has collaborated with scholars based in Japan, Germany and United States. Frequent co-authors include Keiki Sato, Yasuyoshi Kawato, Yasuhide Hirota, Masashi Aonuma, Satoshi Ōmura, Nobutaka Imamura, Yoshinobu Shiose, Mitsuru Hashida, Fumiyoshi Yamashita and Haruo Tanaka. Their work appears in journals such as The Journal of Antibiotics, Bioscience Biotechnology and Biochemistry, Xenobiotica, Biochemical and Biophysical Research Communications and Bioconjugate Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.